Recent advances in the treatment of eosinophilic esophagitis

Abstract

First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of the current literature on EoE has been published in the last 3 years, signaling both a rising incidence and increased recognition of this disorder. Treatment options available for patients with EoE include dietary management and/or pharmacologic therapy. An individualized approach to treatment is preferred, with an emphasis on patient–parental preference. The objective of this article is to discuss the current and future treatment options for EoE.

Keywords::

• atopy patch testing
• biologic compounds
• budesonide
• corticosteroids
• elemental diet
• elimination diet
• fluticasone
• infliximab
• mepolizumab
• prednisone
• skin-prick testing

Financial & competing interests disclosure

Glenn T Furuta is a consultant to Meritage Pharma. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.